Influenza, Pneumococcal and other listed Vaccines

The City of Newark, New Jersey, through its Department of Health and Human Services, is seeking electronic bids for a comprehensive vaccine procurement contract (ITB #2022-55) covering influenza, pneumococcal, and 35 additional vaccine types. The procurement targets approximately 3,000 doses of influenza vaccine and 500 doses of pneumococcal vaccine annually, with bids to be submitted electronically via the City's e-Procurement Portal by November 3, 2022, at 10:15 am. Bidders must provide detailed unit pricing for each vaccine type, with specifications including pack and individual dose configurations. The contract will span two years, with the City reserving the right to adjust quantities based on actual requirements and potentially award contracts to multiple vendors. Evaluation criteria will focus on identifying the lowest responsive and responsible bidder, with the City maintaining discretion to reject bids and waive informalities.

The contract appears open to all qualified vendors who can meet New Jersey state business registration requirements and comply with anti-discrimination and affirmative action provisions. No specific set-aside designations for disadvantaged enterprises were explicitly mentioned in the documentation. The bid emphasizes that no minimum purchase is guaranteed, and vendors must maintain sufficient stock to fulfill emergency orders with pricing remaining firm throughout the contract term. Potential price adjustments may be considered based on manufacturer price lists. While specific budget ranges were not detailed, the comprehensive nature of the vaccine procurement—covering 37 different vaccine types—suggests a potentially significant contract value. Vendors will be expected to provide vaccines across a wide range of medical categories, including but not limited to influenza, hepatitis, rotavirus, and human papillomavirus vaccines, indicating a robust and diverse procurement opportunity.